Preschool Supplement to Clonidine in ADHD (Kiddie-CAT)

Completed · Phase 2 · Has a placebo group

Conditions studied: Attention Deficit Hyperactivity Disorder

In brief

The purpose of this study is to evaluate the safety and efficacy of two medications--clonidine and methylphenidate--alone or in combination to treat attention deficit hyperactivity disorder in children ages 4 through 6.

Key facts

Study ID

NCT00414921

Run by

University of Cincinnati

People needed

30

Starts

2003-09-01

Expected to finish

2007-06-01

Last updated by the study team

2009-05-21

Who can join

Age: 4 and older, up to 6. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Child with ADHD
• Child ages 4 through 6
• Child attending a structured preschool or daycare

You may not qualify if…

• Presence of a tic disorder of any kind or a known active heart disease for which it would be unsafe to use the study drugs
• Presence of pervasive developmental disorder, autism, mental retardation, or serious psychiatric illness
• Child not attending a structured preschool or daycare

Where it is running

• University of Rochester Medical Center, Department of Neurology, 919 Westfall Road, Building C — Rochester, New York, United States
• University of Cincinnati, Department of Psychiatry, 231 Albert Sabin Way, M: 0559 — Cincinnati, Ohio, United States
• Western Psychiatric Institute and Clinic, ADD Program, 3811 Ohara Street — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.